Behind the veneer of accessibility lies a critical bottleneck in clinical trial readiness, especially pronounced in trials ...

has issued a decision to grant Active Biotech’s patent related to use of laquinimod as treatment of eye diseases associated with excessive vascularization. The patent will be granted on May 11 ...

Kodiak Sciences has blamed an “unexpected increase in cataracts” as a reason for the failure of a pair of phase 3 trials that have led the biotech to drop its antibody biopolymer conjugate and ...

Can biotech startups survive a downturn? Is Covid-19 a good business? And when did ophthalmology get so dramatic? We cover all that and more this week on “The Readout LOUD,” STAT’s biotech ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hello, everyone. Damian here with the latest biotech startup to ...